Clinical trials
Observational Hypertension, Portal trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arbor Research Collaborative for Health | 1 |
| Argon Medical Devices | 1 |
| Azienda Ospedaliera Universitaria Integrata Verona | 1 |
| Cook Research Incorporated | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Massachusetts General Hospital | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| University of Arkansas | 1 |
| University of Illinois at Chicago | 1 |
| University of Michigan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension, Portal | 12 |
| Liver Cirrhosis | 7 |
| Fibrosis | 3 |
| Liver Diseases | 3 |
| Ascites | 2 |
| Hepatic Encephalopathy | 2 |
| Alagille Syndrome | 1 |
| Biliary Atresia | 1 |
| Brain Diseases | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.